chr10-74095824-CA-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 9P and 4B. PVS1PP5BS2
The NM_014000.3(VCL):c.1713del(p.Ala573HisfsTer8) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )
Consequence
VCL
NM_014000.3 frameshift
NM_014000.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -2.26
Genes affected
VCL (HGNC:12665): (vinculin) Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 10-74095824-CA-C is Pathogenic according to our data. Variant chr10-74095824-CA-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 468811.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=1}.
BS2
High AC in GnomAdExome4 at 28 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCL | NM_014000.3 | c.1713del | p.Ala573HisfsTer8 | frameshift_variant | 12/22 | ENST00000211998.10 | NP_054706.1 | |
VCL | NM_003373.4 | c.1713del | p.Ala573HisfsTer8 | frameshift_variant | 12/21 | NP_003364.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCL | ENST00000211998.10 | c.1713del | p.Ala573HisfsTer8 | frameshift_variant | 12/22 | 1 | NM_014000.3 | ENSP00000211998 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251308Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135846
GnomAD3 exomes
AF:
AC:
10
AN:
251308
Hom.:
AF XY:
AC XY:
5
AN XY:
135846
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461768Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727186
GnomAD4 exome
AF:
AC:
28
AN:
1461768
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
727186
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74328
GnomAD4 genome
AF:
AC:
1
AN:
152180
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Primary dilated cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 10, 2016 | The p.Ala573HisfsX8 variant in VCL has not been previously reported in individua ls with cardiomyopathy though it was identified in 3/121052 of chromosomes by th e Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). This vari ant is predicted to cause a frameshift, which alters the protein?s amino acid se quence beginning at position 573 and leads to a premature termination codon 8 am ino acids downstream. This alteration is then predicted to lead to a truncated o r absent protein. Current evidence suggests that loss of function of the VCL gen e is associated with dilated cardiomyopathy (DCM). This understanding is based u pon approximately 10 patients with infantile- or childhood- onset DCM that were identified with loss-of-function variants in VCL that also segregated with disea se in five additional family members (LMM, unpublished data). Mouse models have also shown that loss of function of the VCL gene leads to cardiac dysfunction, i ncluding dilated cardiomyopathy (DCM) (Zemljic-Harpf 2007). In summary, although additional studies are required to fully establish its clinical significance, t he p.Ala573HisfsX8 variant is likely pathogenic for dilated cardiomyopathy in an autosomal dominant manner. Data from six families tested in our laboratory sugg est over 50% penetrance of the disease in individuals with a loss-of-function va riant. - |
Dilated cardiomyopathy 1W Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | This sequence change creates a premature translational stop signal (p.Ala573Hisfs*8) in the VCL gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in VCL cause disease. This variant is present in population databases (rs779488376, gnomAD 0.07%). This premature translational stop signal has been observed in individual(s) with clinical features of VCL-related conditions (PMID: 32516855). ClinVar contains an entry for this variant (Variation ID: 468811). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at